Launched in 2007, Therapeutic Advances in Cardiovascular Disease is a gold open access journal publishing clinically focused cardiovascular research that optimises treatment strategies across the care pathway, enables real-world implementation, and improves patient and service outcomes. All articles are made freely available online upon publication, supporting the rapid and global dissemination of evidence that informs patient care. The journal publishes original research articles, systematic and narrative reviews, consensus statements and guidelines, study protocols, and case reports/series that address how cardiovascular disease is treated in practice, with particular emphasis on studies that clarify clinical decision-making, optimise therapeutic strategies, and improve outcomes across diverse patient populations. For more information about article types and topical priorities, please refer to the Aims and Scope page. Our goal is to publish novel research, even if it represents an incremental advance. While our primary focus is on ensuring sound scientific practices, including adherence to ethical standards and the use of robust, transparent, and reproducible methodologies, we recognise the value of incremental contributions to the field. We care more about the quality and reliability of the contribution an article makes than we do the size of that contribution. Therapeutic Advances in Cardiovascular Disease evaluates manuscripts based on how the research was conducted and reported. All submissions undergo rigorous peer review and are evaluated for clinical relevance, methodological quality, and therapeutic impact. Therapeutic Advances in Cardiovascular Disease is indexed in MEDLINE, PubMed Central, Clarivate Analytics' Emerging Sources Citation Index (ESCI), and Scopus, and is a member of the Committee on Publication Ethics (COPE) . Accessible formats and article enhancements Therapeutic Advances in Cardiovascular Disease also offers alternative article formats including Plain Language Summaries of Publications (PLS-Ps; standalone, peer-reviewed summaries of previously published articles), and podcast and clinical image articles, as well as article enhancements such as video abstracts and infographics. These formats extend the journal's educational reach, helping clinicians, generalist healthcare professionals, patients, caregivers, and policymakers engage with evidence, and align with our commitment to inclusive, real-world communication. For queries about these formats, please contact Dr. Amy Goundry at amy.goundry@sagepub.co.uk prior to submission. Diversity, Equity and Inclusion statement Therapeutic Advances in Cardiovascular Disease promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the research community. Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives. We welcome editors, editorial board members, peer reviewers, and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status, or any other individual status. We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms. Submission information Submit your manuscript at http://mc.manuscriptcentral.com/tac . Please see the Submission Guidelines for more information on preparing and submitting your article. Open access information The article processing charge (APC) for this journal is currently $3000 USD*. *APC for original research articles, brief reports, systematic reviews and meta-analyses, narrative reviews, study protocols, and case reports/series. Pre -submission queries Pre-submission enquiries are welcome. Authors proposing accessible formats (i.e., PLS-Ps and podcast or clinical image articles) should contact the Managing Editor before submitting. We also invite general questions about scope alignment, clinical positioning, and submissions to current Special Collections. Please direct pre-submission queries to Dr. Amy Goundry at amy.goundry@sagepub.co.uk . Subject line: TAK Pre-Submission Query — [Article Type] — [Special Collection, if any] For questions about a submitted paper or to request an extension for a review or revision, please contact the journal's editorial office at cardio@sagepub.co.uk .
